Sara E. Mole
Affiliations: | MRC LMCB | University College London, London, United Kingdom |
Area:
genetic disease, neurodegeneration, lysosomes, Batten disease, Chediak-Higashi SyndromeWebsite:
http://www.ucl.ac.uk/lmcb/research-groups/mole.htmGoogle:
"Sara Mole"Cross-listing: Batten Disease Tree
Children
Sign in to add traineeRebecca L. Haines | grad student | 2005-2009 | UCL |
Sandra Codlin | post-doc | 2002-2009 | UCL |
Collaborators
Sign in to add collaboratorFred Chang | collaborator | 2005- | UCL |
Jerry Hyams | collaborator | 2001-2005 | UCL |
Yannick Gachet | collaborator | 2002-2005 | UCL |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zhang HY, Minnis C, Gustavsson E, et al. (2024) CLN3 transcript complexity revealed by long-read RNA sequencing analysis. Bmc Medical Genomics. 17: 244 |
Ofrim M, Little D, Nazari M, et al. (2023) Characterization of two human induced pluripotent stem cell lines derived from Batten disease patient fibroblasts harbouring CLN5 mutations. Stem Cell Research. 74: 103291 |
Relton EL, Roth NJ, Yasa S, et al. (2023) The Batten disease protein CLN3 is important for stress granules dynamics and translational activity. The Journal of Biological Chemistry. 104649 |
Lopez-Fabuel I, Garcia-Macia M, Buondelmonte C, et al. (2022) Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis. Nature Communications. 13: 536 |
Gardner E, Mole SE. (2021) The Genetic Basis of Phenotypic Heterogeneity in the Neuronal Ceroid Lipofuscinoses. Frontiers in Neurology. 12: 754045 |
Soldati C, Lopez-Fabuel I, Wanderlingh LG, et al. (2021) Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype. Embo Molecular Medicine. e13742 |
Minnis CJ, Townsend S, Petschnigg J, et al. (2021) Global network analysis in Schizosaccharomyces pombe reveals three distinct consequences of the common 1-kb deletion causing juvenile CLN3 disease. Scientific Reports. 11: 6332 |
Lourenço CM, Pessoa A, Mendes CC, et al. (2020) Revealing the clinical phenotype of atypical neuronal ceroid lipofuscinosis type 2 disease: Insights from the largest cohort in the world. Journal of Paediatrics and Child Health |
Kleine Holthaus SM, Aristorena M, Maswood R, et al. (2020) Gene therapy targeting the inner retina rescues the retinal phenotype in a mouse model of CLN3 Batten disease. Human Gene Therapy |
Rahim AA, Russell C, Mole SE. (2020) Special edition: The NCLs/Batten disease. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 165824 |